TransScan Medical Inc.
This article was originally published in Start Up
Executive Summary
Diagnostic Imaging; Breast Cancer. TransScan Medical is developing a new diagnostic modality that it will initially market to radiologists as an adjunct to mammography. The company's technology is based on the electrical impedance properties of tissue.
You may also be interested in...
Device Start-Ups for the Second Sex
Women's health has been a tough market to get a handle on because it's a highly fragmented set of small markets, plagued by reimbursement difficulties. But if venture capitalists aren't gung ho, large companies are--and are encouraging new companies to develop their ideas with the possibility of a high-value acquisition down the road.
Despite 'Remarkable' ROI On Women’s Health Investments, Money Still Lacking
Recent US government initiatives and growing investor interest are important for developing female-specific therapeutics, but funding is not yet where it should be.
China VBP, Localization And Other Strategies - How Far And Which Way?
Could health sector players encounter issues similar to those facing Tesla in China, a country which virtually saved the electric vehicle maker but where it is now facing challenges? Are there any lessons to be learned from a success story under China's volume-based procurement scheme? A partner at EY looks at these and other issues in an interview with Scrip.